ATRS Overview
Upcoming Projects (ATRS)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ATRS)
-
Discussing Antares's and Lipocine's TLANDO for testosterone replacement therapy, following its receipt of US FDA approval March 29, 2022
Tickers: ATRS, LPCN, HALO
Executed On: Apr 13, 2022 at 04:00 PM EDT
Upcoming & Overdue Catalysts (ATRS)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (ATRS)
-
Antares (ATRS) Files NDA with FDA for QuickShot Testosterone Subcutaneous Device
Ticker: ATRS
Occurred on: Dec 21, 2016 -
TEVA and Antares Pharma Announce Launch of Generic Imitrex in the United States
Tickers: TEVA, ATRS
Occurred on: Jun 23, 2016 -
Antares Pharma Announces Settlement of Patent Litigation for Key Alliance Business Product
Ticker: ATRS
Occurred on: Jun 23, 2016
Strategic Initiatives (ATRS)
-
Antares Pharma (ATRS) Enters into a Development Agreement with Pfizer (PFE) to develop a combination drug device rescue pen
Tickers: ATRS, PFE
Announcement Date: Aug 06, 2018
